Fridman R - Search Results

1

TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain.

Jung YS, Liu XW, Chirco R, Warner RB, Fridman R, Kim HR. Jung YS, et al. Among authors: fridman r. PLoS One. 2012;7(6):e38773. doi: 10.1371/journal.pone.0038773. Epub 2012 Jun 11. PLoS One. 2012. PMID: 22701711 Free PMC article.

2

Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.

Jung KK, Liu XW, Chirco R, Fridman R, Kim HR. Jung KK, et al. Among authors: fridman r. EMBO J. 2006 Sep 6;25(17):3934-42. doi: 10.1038/sj.emboj.7601281. Epub 2006 Aug 17. EMBO J. 2006. PMID: 16917503 Free PMC article.

3

TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells.

D'Angelo RC, Liu XW, Najy AJ, Jung YS, Won J, Chai KX, Fridman R, Kim HR. D'Angelo RC, et al. Among authors: fridman r. Mol Cancer Res. 2014 Sep;12(9):1324-33. doi: 10.1158/1541-7786.MCR-14-0105. Epub 2014 Jun 3. Mol Cancer Res. 2014. PMID: 24895412 Free PMC article.

4

Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway.

Liu XW, Bernardo MM, Fridman R, Kim HR. Liu XW, et al. Among authors: fridman r. J Biol Chem. 2003 Oct 10;278(41):40364-72. doi: 10.1074/jbc.M302999200. Epub 2003 Aug 5. J Biol Chem. 2003. PMID: 12904305 Free article.

5

Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1.

Liu XW, Taube ME, Jung KK, Dong Z, Lee YJ, Roshy S, Sloane BF, Fridman R, Kim HR. Liu XW, et al. Among authors: fridman r. Cancer Res. 2005 Feb 1;65(3):898-906. Cancer Res. 2005. PMID: 15705888

6

Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.

Sabbota AL, Kim HR, Zhe X, Fridman R, Bonfil RD, Cher ML. Sabbota AL, et al. Among authors: fridman r. Cancer Res. 2010 Jul 1;70(13):5558-66. doi: 10.1158/0008-5472.CAN-09-4416. Epub 2010 Jun 15. Cancer Res. 2010. PMID: 20551048 Free PMC article.

7

Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.

Kim S, Huang W, Mottillo EP, Sohail A, Ham YA, Conley-Lacomb MK, Kim CJ, Tzivion G, Kim HR, Wang S, Chen YQ, Fridman R. Kim S, et al. Among authors: fridman r. Biochim Biophys Acta. 2010 Nov;1803(11):1287-97. doi: 10.1016/j.bbamcr.2010.06.011. Epub 2010 Jul 8. Biochim Biophys Acta. 2010. PMID: 20620173 Free PMC article.

8

Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy.

Warner RB, Najy AJ, Jung YS, Fridman R, Kim S, Kim HC. Warner RB, et al. Among authors: fridman r. Sci Rep. 2020 Feb 7;10(1):2099. doi: 10.1038/s41598-020-58964-x. Sci Rep. 2020. PMID: 32034211 Free PMC article.

9

Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells.

Li G, Fridman R, Kim HR. Li G, et al. Among authors: fridman r. Cancer Res. 1999 Dec 15;59(24):6267-75. Cancer Res. 1999. PMID: 10626822

10

PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer.

Conley-LaComb MK, Huang W, Wang S, Shi D, Jung YS, Najy A, Fridman R, Bonfil RD, Cher ML, Chen YQ, Kim HC. Conley-LaComb MK, et al. Among authors: fridman r. Am J Pathol. 2012 Mar;180(3):1017-1027. doi: 10.1016/j.ajpath.2011.11.021. Epub 2011 Dec 28. Am J Pathol. 2012. PMID: 22209699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters